NEW APPROACHES TO THE MANAGEMENT OF WOMEN WITH ENDOMETRIAL HYPERPLASIA
PDF
DOI

Keywords

Endometrial hyperplasia (EH), endometrial cancer (EC), polycystic ovary syndrome (POS), hormone therapy (HT), progestins, atypical endometrial hyperplasia (AEH), complex non-atypical endometrial hyperplasia (CNAEH), abnormal uterine mottling (AUM), adenocarcinoma.

How to Cite

NEW APPROACHES TO THE MANAGEMENT OF WOMEN WITH ENDOMETRIAL HYPERPLASIA. (2024). Journal of Science-Innovative Research in Uzbekistan, 2(6), 148-153. https://universalpublishings.com/~niverta1/index.php/jsiru/article/view/6192

Abstract

To date, endometrial hyperplasia (hereinafter referred to as EH) is considered the most common disease in gynecology. Timely complex diagnostics of endometrial pathology allows to achieve good results of treatment: stabilization and elimination of pathological foci, thus preserving and restoring reproductive function.

PDF
DOI

References

Contreras NA, Sabadell J, Verdaguer P, Julià C, Fernández-Montolí ME.

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions. Int J Mol Sci. 2022 Feb

;23(5) [PMC free article] [PubMed]

Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022 Aug;306(2):407-421. [PMC free article] [PubMed] 3.Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017 Mar 01;23(2):232-254. [PMC free article] [PubMed]

Shen Y, Yang W, Liu J, Zhang Y. Minimally invasive approaches for the early detection of endometrial cancer. Mol Cancer. 2023 Mar 17;22(1):53. [PMC

free article] [PubMed]

Lathigara D, Kaushal D, Wilson RB. Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis-A Narrative Review. Metabolites. 2023 May 21;13(5) [PMC free article] [PubMed] 6.Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009 Sep;19(3):398-405. [PubMed] 7.Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003 Mar 15;21(6):1180-9. [PubMed] 8.Lee M, Piao J, Jeon MJ. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen. Yonsei Med J. 2020 Apr;61(4):317-322. [PMC free article] [PubMed] 9.Lancaster JM, Powell CB, Chen LM, Richardson DL., SGO Clinical Practice Committee. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2015 Jan;136(1):3-

[PubMed]

Ryan NAJ, McMahon R, Tobi S, Snowsill T, Esquibel S, Wallace AJ, Bunstone S, Bowers N, Mosneag IE, Kitson SJ, O'Flynn H, Ramchander NC, Sivalingam VN, Frayling IM, Bolton J, McVey RJ, Evans DG, Crosbie EJ. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study. PLoS Med. 2020 Sep;17(9):e1003263. [PMC free

article] [PubMed]

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7-33. [PubMed] 12.Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73(1):17-48. [PubMed] 13.Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016 Mar 12;387(10023):1094-1108. [PubMed] 14. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982 Jun 15;49(12):2547-59.[PubMed]

Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012 May;125(2):477-82. [PubMed] 16. Cancer Genome Atlas Research Network. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA.

Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 02;497(7447):67-73. [PMC free article] [PubMed] 17. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, Alberts D, Curtin J. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006 Feb 15;106(4):812-9. [PubMed] 18. Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, Oaknin A. Endometrial cancer. Nat Rev Dis Primers. 2021 Dec 09;7(1):88. [PMC

free article] [PubMed]

White K, Potter JE, Hopkins K, Fernández L, Amastae J, Grossman D.

Contraindications to progestin-only oral contraceptive pills among reproductive- aged women. Contraception. 2012 Sep;86(3):199-203. [PMC free article] [PubMed] 20.Ring KL, Mills AM, Modesitt SC. Endometrial Hyperplasia. Obstet Gynecol. 2022 Dec 01;140(6):1061-1075. [PubMed]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.